The role of episin-bar virus in cancer after kidney transplantation

The cause of the complication is the epistemic bar (EBV), according to the Mehr correspondent. The episin bar virus, known for the creation of mononucleosis, is also associated with the risk of several cancers, including PTLD.

When kidney transplant patients who have never been exposed to a donor carrying the virus, they can develop PTLD.

For this study, the researchers analyzed the data of two major links in the United States. They compared the amount of EBV among kidney transplant recipients whose donors were positive in terms of virus.

Studies showed that 5 % of transplant recipients had never been contaminated by the kidney from the donor contaminated with the virus, they had PTLD within three years after transplantation.

Nearly one -third of those affected by PTLD died during the study period.

People who receive kidney transplants should use immune suppressing drugs to prevent their body from rejecting new kidney. According to the National Kidney Foundation, these drugs increase the risk of EBV -related PTLD.

New data show that up to 5 % of kidney transplant recipients can be at risk for PTLD.

“The risk of PTLD diagnosis has been widely recognized after kidney transplantation, but so far, it has been largely studied in children who are less exposed to EBV,” said Dr. Vishnu Potlori, author of the study at Pennsylvania University in Philadelphia It is. “

“Given the considerable threat that PTLD creates for survival and the fundamental difference between our findings and previous data, our study as a call to take prioritization to increase the safety and survival of this population. The bond can be operated. “